- Citations, last 5 years
- 680
- Works, last 5 years
- 184
- h-index
- 83
- Scientists listed
- 13
- Grants since 2016
- 1 402
Grants received
2022–2024 · fellowship · F32
Developing a Temporally-Regulated Gene Therapy for Therapeutic Angiogenesis
Mai Ngo · Charles River Associates · funded by National Institutes of Health
2022–2025 · fellowship · F31
Simultaneous optical voltage imaging and fMRI in behaving mice
Patrick Doran · Charles River Associates · funded by National Institutes of Health
2022–2023 · grant · S10
Acquisition of a Surface Plasmon Resonance Instrument
Adrian Whitty · Charles River Associates · funded by National Institutes of Health
2022–2027 · training · T32
Training Program in Quantitative Biology & Physiology (QBP)
John A. White · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
A Bio-inspired Latent TGF-beta Conjugated Scaffold for Patient-specific Cartilage Regeneration
Michael B Albro · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Neurophotonic Advances for Mechanistic Investigation of the Role of Capillary Dysfunction in Stroke Recovery
David A Boas · Charles River Associates · funded by National Institutes of Health
2022–2024 · fellowship · F32
Detecting and classifying non-fluent speech in aphasia using machine learning
Claire Elizabeth Cordella · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · R01
CRCNS: Neural Representations of Time Across Scales in Natural and Artificial Networks
Marc W Howard · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · RF1
Sensory-motor strategies for odor-guided navigation
Ian Gordon Davison · Charles River Associates · funded by National Institutes of Health
2022–2026 · research · R01
Using Machine Learning to Optimize User Engagement and Clinical Response to Digital Mental Health Interventions
Todd J. Farchione · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · R21
Interferometric Plasmon Ruler for Elucidating Structural Dynamics on the SingleMolecule Level
Bjoern Markus Reinhard · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · R21
Frequency domain shortwave infrared spectroscopy (FD-SWIRS) for volume status monitoring during hemodialysis in end stage kidney disease
Vipul C Chitalia · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · R01
High-content High-speed Chemical Imaging of Metabolic Reprogramming by Integration of Advanced Instrumentation and Data Science
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2022–2026 · research · R01
Biodegradable, Biocompatible Pressure Sensitive Adhesives
Yolonda L Colson · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Computational Miniature Mesoscope for Cortex-wide, Cellular resolution Ca2+ Imaging in Freely Behaving Mice
Lei Tian · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Alcohol and "Heat of the Moment" Sexual Decision Making among MSM: Identifying Mechanisms of Sexual Risk and Promoting Behavior Change Through Brief Intervention
Stephen A Maisto · Charles River Associates · funded by National Institutes of Health
2022–2024 · fellowship · F31
Musical rhythm synchronization as a mechanism to optimize gait in the real-world in persons with Parkinson disease
Jenna Zajac · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
2/2-CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
Michael W. Otto · Charles River Associates · funded by National Institutes of Health
2022–2025 · research · R01
High-content High-speed Chemical Imaging of Metabolic Reprogramming by Integration of Advanced Instrumentation and Data Science
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2022–2024 · research · R01
Functional heterogeneity of vasoactive intestinal peptide-expressing interneurons in the anterior cingulate cortex
Alberto Cruz-Martin · Charles River Associates · funded by National Institutes of Health
2022–2025 · fellowship · F31
Predictors of Speech Motor Sequence Learning in Neurological Disorders
Hilary Elizabeth Miller · Charles River Associates · funded by National Institutes of Health
2022–2024 · fellowship · F31
Musical rhythm synchronization as a mechanism to optimize gait in the real-world in persons with Parkinson disease
Jenna Zajac · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Computational Miniature Mesoscope for Cortex-wide, Cellular resolution Ca2+ Imaging in Freely Behaving Mice
Lei Tian · Charles River Associates · funded by National Institutes of Health
2022–2024 · fellowship · F32
Validation of an automated acoustic outcome measure for AdLD
Katherine Lindsey Marks · Charles River Associates · funded by National Institutes of Health
2022–2023 · fellowship · F32
Subcellular Mapping and Post-Synaptic Impacts of Striatal Dopamine Release During Behavior
Mai-Anh Vu · Charles River Associates · funded by National Institutes of Health
2022–2025 · fellowship · F31
How Does Attention and Arousal Interact to Modulate Vision?
Jasmine Pan · Charles River Associates · funded by National Institutes of Health
2022–2024 · research · R21
Leveraging Machine Learning Techniques to Elucidate Risk for Callous-Unemotional Traits
Nicholas J Wagner · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
A Bio-inspired Latent TGF-beta Conjugated Scaffold for Patient-specific Cartilage Regeneration
Michael B Albro · Charles River Associates · funded by National Institutes of Health
2022–2024 · research · R21
Interferometric Plasmon Ruler for Elucidating Structural Dynamics on the SingleMolecule Level
Bjoern Markus Reinhard · Charles River Associates · funded by National Institutes of Health
2022–2026 · research · R34
Ultrafast high-contrast voltage imaging in freely moving animals
Jerome Mertz · Charles River Associates · funded by National Institutes of Health
2022–2027 · career development · K23
Reducing psychological barriers to PrEP persistence among pregnant and postpartum women in Cape Town, South Africa
Amelia M. Stanton · Charles River Associates · funded by National Institutes of Health
2022–2024 · fellowship · F32
Validation of an automated acoustic outcome measure for AdLD
Katherine Lindsey Marks · Charles River Associates · funded by National Institutes of Health
2022–2024 · fellowship · F32
Detecting and classifying non-fluent speech in aphasia using machine learning
Claire Elizabeth Cordella · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder
Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation
Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health
2022 · fellowship · F32
Detecting and classifying non-fluent speech in aphasia using machine learning
Claire Elizabeth Cordella · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Alcohol and "Heat of the Moment" Sexual Decision Making among MSM: Identifying Mechanisms of Sexual Risk and Promoting Behavior Change Through Brief Intervention
Stephen A Maisto · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Programmable benchtop bioreactors for scalable eco-evolutionary dynamics of the human microbiome
Ahmad Samir Khalil · Charles River Associates · funded by National Institutes of Health
2022–2027 · research · R01
Arthroscopic Raman Monitoring of Cartilage Content for PTOA Diagnosis and Chondroregenerative Treatment Response
Michael B Albro · Charles River Associates · funded by National Institutes of Health
2022–2024 · fellowship · F32
Developing a Temporally-Regulated Gene Therapy for Therapeutic Angiogenesis
Mai Ngo · Charles River Associates · funded by National Institutes of Health